GCP
LOXO

GSA Capital Partners’s Loxo Oncology, Inc LOXO Stock Holding History

GSA Capital Partners’s Portfolio LOXO Stock Details LOXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-2,615
Closed -$454K – 2058
2018
Q2 		$454K Buy
+2,615
New +$393K 0.02% 1201
2017
Q1 		– Sell
-13,900
Closed -$446K – 2135
2016
Q4 		$446K Buy
13,900
+1,760
+14% +$45.1K 0.03% 1070
2016
Q3 		$318K Sell
12,140
-2,300
-16% -$60.2K 0.02% 1329
2016
Q2 		$335K Buy
14,440
+1,740
+14% +$43.3K 0.02% 1325
2016
Q1 		$347K Sell
12,700
-24,400
-66% -$511K 0.02% 1231
2015
Q4 		$1.05M Buy
+37,100
New +$996K 0.05% 662

Other funds holding LOXO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

GSA Capital Partners's LOXO Position: Q3 2018 in Review

GSA Capital Partners sold out of Loxo Oncology, Inc (LOXO) in Q3 2018, closing a stake of 2,615 shares — an estimated $454K sold.

GSA Capital Partners first reported a position in LOXO in Q4 2015 and held it in 6 quarters. The position peaked at $1.05M in Q4 2015. 228 funds tracked by Wall St. Rank hold LOXO as of Q3 2018.

  • GSA Capital Partners reported no remaining Loxo Oncology, Inc position as of Q3 2018 after selling out during the quarter.
  • GSA Capital Partners sold 2,615 Loxo Oncology, Inc shares in Q3 2018, an estimated $454K.
  • GSA Capital Partners first reported a position in Loxo Oncology, Inc in Q4 2015 and held it in 6 quarters.
  • GSA Capital Partners's Loxo Oncology, Inc position peaked at $1.05M in Q4 2015.
  • 228 funds tracked by Wall St. Rank held Loxo Oncology, Inc as of Q3 2018.

Based on GSA Capital Partners's 13F filing for Q3 2018, filed 13 Nov 2018.